Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Manuka oil is a plant-derived essential oil extracted from the manuka plant (*Leptospermum scoparium*), native to New Zealand. It is being investigated by the University of Otago (Sir John Walsh Research Institute, Faculty of Dentistry) as a topical antimicrobial agent for the treatment of gingivitis and periodontal disease. The oil's primary bioactive constituents are triketones, including leptospermone and related beta-triketones, which exhibit potent antibacterial activity against gram-negative periodontal pathogens. In clinical research, it has been formulated as a topical hydrogel and evaluated in randomized controlled trials for human experimental gingivitis. Additionally, research has explored nanoencapsulated chitosan-based delivery systems to enhance its therapeutic efficacy in the oral cavity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on manuka oil.